Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) ...

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

In addition to supporting NurExone's internal drug development efforts, Exo-Top will be positioned to supply high-quality exosomes to other pharmaceutical ... greater control over its exosome ...

Such growth makes China an increasingly important player in the global biopharmaceutical industry, offering potential market ...

The aquaculture industry is suffering significant financial losses as a result of the worsening water quality and increasing ... resulting in drug residues in aquatic products, severely impeding the ...

marking a transformative step in how Conduit would develop and deliver drug development. By leveraging AI, the Company is seeking to streamline drug repurposing, accelerate drug discovery ...